UBS Group’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-18,600
Closed -$783K – 10561
2025
Q3
$783K Buy
+18,600
New +$926K ﹤0.01% 5755
2025
Q1
– Sell
-3,000
Closed -$208K – 10265
2024
Q4
$208K Buy
+3,000
New +$288K ﹤0.01% 6432
2018
Q4
– Sell
-18,500
Closed -$2.11M – 8039
2018
Q3
$2.11M Hold
18,500
– – ﹤0.01% 3182
2018
Q2
$2.06M Buy
+18,500
New +$2.04M ﹤0.01% 3139
2017
Q2
– Sell
-89,352
Closed -$8.03M – 7693
2017
Q1
$8.03M Buy
+89,352
New +$7.8M ﹤0.01% 1678
2016
Q2
– Sell
-89,352
Closed -$5.85M – 7739
2016
Q1
$5.85M Buy
+89,352
New +$5.54M ﹤0.01% 1733
2015
Q3
– Sell
-200
Closed -$14K – 8419
2015
Q2
$14K Sell
200
-2,300
-92% -$153K ﹤0.01% 7181
2015
Q1
$140K Sell
2,500
-300
-11% -$17K ﹤0.01% 5160
2014
Q4
$168K Buy
+2,800
New +$164K ﹤0.01% 5205

Other funds holding CE

UBS Group's CE Position: Q3 2026 in Review

UBS Group increased its Celanese (CE) stake by 14% in Q3 2026, buying an estimated $11.2M and bringing the position to 1,938,579 shares worth $86M. The position accounts for 0.01% of the portfolio, ranked #1214.

UBS Group first reported a position in CE in Q4 2014 and has held it in 48 quarters since. The position peaked at $102M in Q4 2024. 443 funds tracked by Wall St. Rank hold CE as of Q3 2026.

  • UBS Group held 1,938,579 shares of Celanese worth $86M as of Q3 2026.
  • UBS Group bought 244,183 Celanese shares in Q3 2026, an estimated $11.2M.
  • Celanese made up 0.01% of UBS Group's portfolio in Q3 2026, its #1214 holding.
  • UBS Group first reported a position in Celanese in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Celanese position peaked at $102M in Q4 2024.
  • 443 funds tracked by Wall St. Rank held Celanese as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.